Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis

Oncogene

Volumn 22, Issue 49, 2003, Pages 7831-7837

  Moore, Lynette ^a   Venkatachalam, Sundaresan ^b   Vogel, Hannes ^c   Watt, Julie C ^a   Wu, Chao Ling ^a   Steinman, Heather ^d   Jones, Stephen N ^d   Donehower, Lawrence A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

19ARF; Mdm2; Mouse cancer model; p53; Tumor suppressor

Indexed keywords

PROTEIN MDM2; PROTEIN P19; PROTEIN P53; CDKN2A PROTEIN, MOUSE; MDM2 PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN P14ARF; PROTEIN P16INK4A;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; CANCER INCIDENCE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; GENOTYPE; HEALTH STATUS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REGULATORY MECHANISM; WILD TYPE; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENETICS; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALIA; MURINAE; MUS MUSCULUS;

ALLELES; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344441868     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206985     Document Type: Article

References (44)

1. Alarcon-Vargas D and Ronai Z. (2002). Carcinogenesis, 23, 541-547.
2. Appella E and Anderson CW. (2001). Eur. J. Biochem., 268, 2764-2772.
3. Bai F, Pei XH, Godfrey VL and Xiong Y. (2003). Mol. Cell. Biol., 23, 1269-1277.
4. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
5. Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL. (1999). Genes Dev., 13, 2658-2669.
6. Eymin B, Leduc C, Coll JL, Brambilla E and Gazzeri S. (2003). Oncogene, 22, 1822-1835.
7. Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ. (1998). Nature, 396, 177-180.
8. Foster CJ and Lozano G. (2002). Oncogene, 21, 3525-3531.
9. Harvey M, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A and Donehower LA. (1993). Nat. Genet., 5, 225-229.
10. Jones SN, Hancock AR, Vogel H, Donehower LA and Bradley A. (1998). Proc. Natl. Acad. Sci. USA, 95, 15608-15612.
11. Jones SN, Roc AE, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
12. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH. (1994). Science, 264, 436-440.
13. Kamijo T, Bodner S, van de Kamp E, Randle DH and Sherr CJ. (1999). Cancer Res., 59, 2217-2222.
14. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 8292-8297.
15. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
16. Knudson Jr AG. (1984). Cancer Detect. Prev., 7, 1-8.
17. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A and Berns A. (2001). Nature, 413, 83-86.
18. Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ and Roussel MF. (2003). Cancer Res., 63, 1046-1053.
19. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW and Vogelstein B. (1993). Cancer Res., 53 (Suppl.), 2231-2234.
20. Levine AJ. (1997). Cell, 88, 323-331.
21. Ljungman M. (2000). Neoplasia, 2, 208-225.
22. Lozano G and Elledge SJ. (2000). Nature, 404, 24-25.
23. McDonnell TJ, Montes de Oca Luna R, Cho S, Amelse LL, Chavez-Reyes A and Lozano G. (1999). J. Pathol., 188, 322-328.
24. Michael D and Oren M. (2002). Curr. Opin. Genet. Dev., 12, 53-59.
25. Montes de Oca Luna R, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
26. Palmero I, Pantoja C and Serrano M. (1998). Nature, 395, 125-126.
27. Reinke V, Bortner DM, Amelse LL, Lundgren K, Rosenberg MP, Finlay CA and Lozano G. (1999). Cell Growth Differ., 10, 147-154.
28. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA. (1996). Cell, 85, 27-37.
29. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA. (2001). Nature, 413, 86-91.
30. Sharpless NE, Ferguson DO, O'Hagan RC, Castrillon DH, Lee C, Farazi PA, Alson S, Fleming J, Morton CC, Frank K, Chin L, Alt FW and DePinho RA. (2001). Mol. Cell, 8, 1187-1196.
31. Sherr CJ. (2001). Nat. Rev. Mol. Cell. Biol., 2, 731-737.
32. Sherr CJ and Weber JD. (2000). Curr. Opin. Genet. Dev., 10, 94-99.
33. Tao W and Levine AJ. (1999). Proc. Natl. Acad. Sci. USA, 96, 6937-6941.
34. Tsai KY, MacPherson D, Rubinson DA, Nikitin AY, Bronson R, Mercer KL, Crowley D and Jacks T. (2002). Proc. Natl. Acad. Sci. USA, 99, 16865-16870.
35. Tsuji K, Mizumoto K, Sudo H, Kouyama K, Ogata E and Matsuoka M. (2002). Biochem. Biophys. Res. Commun., 295, 621-629.
36. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D and Donehower LA. (1998). EMBO J., 17, 4657-4667.
37. Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE and Donehower LA. (2001). Toxicol. Pathol., 29 (Suppl.), 147-154.
38. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-309.
39. Vousden KH and Lu X. (2002). Nat. Cancer Rev., 2, 594-604.
40. Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ and Zambetti GP. (2000). Genes Dev., 14, 2358-2365.
41. Weber HO, Samuel T, Rauch P and Funk JO. (2002). Oncogene, 21, 3207-3212.
42. Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D. (1999). Nat. Cell Biol., 1, 20-26.
43. Zhang Y, Xiong Y and Yarbrough WG. (1998). Cell, 92, 725-734.
44. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.